200,000+ products from a single source!

sales@angenechem.com

Home > Oxazole > 53602-00-9

53602-00-9

53602-00-9 | 4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol

CAS No: 53602-00-9 Catalog No: AG00E3DK MDL No:

Product Description

Catalog Number:
AG00E3DK
Chemical Name:
4,5,6,7-tetrahydroisoxazolo(4,5-c)pyridin-3-ol
CAS Number:
53602-00-9
IUPAC Name:
4,5,6,7-tetrahydro-[1,2]oxazolo[4,5-c]pyridin-3-one
InChI:
InChI=1S/C6H8N2O2/c9-6-4-3-7-2-1-5(4)10-8-6/h7H,1-3H2,(H,8,9)
InChI Key:
SXXLKZCNJHJYFL-UHFFFAOYSA-N

Properties

Complexity:
210  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
140.059g/mol
Formal Charge:
0
Heavy Atom Count:
10  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
140.142g/mol
Monoisotopic Mass:
140.059g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
50.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.9  

Literature

Title Journal
The SLC36 family of proton-coupled amino acid transporters and their potential role in drug transport. British journal of pharmacology 20111201
Non-neuronal, slow GABA signalling in the ventrobasal thalamus targets δ-subunit-containing GABA(A) receptors. The European journal of neuroscience 20110401
Inhibition of thalamic excitability by 4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridine-3-ol: a selective role for delta-GABA(A) receptors. The European journal of neuroscience 20090301
Transport of amino acids and GABA analogues via the human proton-coupled amino acid transporter, hPAT1: characterization of conditions for affinity and transport experiments in Caco-2 cells. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20080902
Effect of microdialysis perfusion of 4,5,6,7-tetrahydroisoxazolo-[5,4-c]pyridine-3-ol in the perifornical hypothalamus on sleep-wakefulness: role of delta-subunit containing extrasynaptic GABAA receptors. Neuroscience 20080515
Mutations of the 2' proline in the M2 domain of the human GABAC rho1 subunit alter agonist responses. Neuropharmacology 20040501
Effects of 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazol (exo-THPO) and its N-substituted analogs on GABA transport in cultured neurons and astrocytes and by the four cloned mouse GABA transporters. Neurochemistry international 20030101
Prenatal protein malnutrition enhances stimulus control by CDP, but not a CDP/THIP combination in rats. Pharmacology, biochemistry, and behavior 20021101
Correlation between anticonvulsant activity and inhibitory action on glial gamma-aminobutyric acid uptake of the highly selective mouse gamma-aminobutyric acid transporter 1 inhibitor 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole and its N-alkylated analogs. The Journal of pharmacology and experimental therapeutics 20020801
Potentiation of GABA(A) receptor agonists by GABA uptake inhibitors in the rat ventral midbrain. European journal of pharmacology 20010928
Characterization of discriminative stimulus effects of the neuroactive steroid pregnanolone. The Journal of pharmacology and experimental therapeutics 20010501
Anticonvulsant activity of the glial-selective GABA uptake inhibitor, THPO. Neuropharmacology 19830101

Related Products

© 2019 Angene International Limited. All rights Reserved.